We’ve told you a lot over the past few months about the medical concerns linked to testosterone or “Low T” drugs. The FDA has now woken up from its slumber on this and is now requiring the manufactures of AndroGel and other testosterone replacement drugs manufacturers to add new warnings about the link between the medications and potential blood clots, including DVT (deep vein thrombosis), pulmonary embolism, or VTE (venous thromboembolism). If you have been following for this at all, this comes as no surprise. This was predictable as a new crisis in Kim Kardashian life.
WHY THESE CASES WILL NOW BE EASIER TO SETTLE
What does it mean? Well, it is going to make settling these cases a lot easier. Why? Now we have a new warning. I’ll bet these cases eventually get divided for settlement purposes in cases where the injury was before the warning and cases where the injury was after the warning.